These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32868151)

  • 21. Characterizing Predictors and Severity of Vasoplegia Syndrome After Heart Transplantation.
    Chan JL; Kobashigawa JA; Aintablian TL; Dimbil SJ; Perry PA; Patel JK; Kittleson MM; Czer LS; Zarrini P; Velleca A; Rush J; Arabia FA; Trento A; Esmailian F
    Ann Thorac Surg; 2018 Mar; 105(3):770-777. PubMed ID: 29289367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II in Refractory Septic Shock.
    Antonucci E; Gleeson PJ; Annoni F; Agosta S; Orlando S; Taccone FS; Velissaris D; Scolletta S
    Shock; 2017 May; 47(5):560-566. PubMed ID: 27879559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of methylene blue to treat vasoplegia syndrome in cystic fibrosis patients undergoing lung transplantation: A case series.
    Washington GC; O'Donnell CT; Madhok J; Williams KM; Hill CC
    Ann Card Anaesth; 2023; 26(1):36-41. PubMed ID: 36722586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylene Blue for Vasoplegic Syndrome.
    Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
    Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catecholamine-Sparing Effect of Angiotensin II in an Anephric Patient With Mixed Shock After Cardiac Revascularization Surgery: A Case Report.
    Cutler NS; Khanna AK
    A A Pract; 2020 Jul; 14(9):e01266. PubMed ID: 32909718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoresponsiveness in patients with heart failure (VASOR): protocol for a prospective observational study.
    van Vessem ME; Beeres SLMA; de Wilde RBP; de Vries R; Berendsen RR; de Jonge E; Danser AHJ; Klautz RJM; Schalij MJ; Palmen M
    J Cardiothorac Surg; 2019 Nov; 14(1):200. PubMed ID: 31752946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of the renin-angiotensin system in septic shock: Mechanistic insights and application of angiotensin II in clinical management.
    Senatore F; Balakumar P; Jagadeesh G
    Pharmacol Res; 2021 Dec; 174():105916. PubMed ID: 34597810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
    Nash CM
    AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoplegia in patients following ventricular assist device explant and heart transplantation.
    Emmanuel S; Pearman M; Jansz P; Hayward CS
    Perfusion; 2022 Mar; 37(2):152-161. PubMed ID: 33482711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.
    Ortoleva J; Shapeton A; Vanneman M; Dalia AA
    J Cardiothorac Vasc Anesth; 2020 Oct; 34(10):2766-2775. PubMed ID: 31917073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoplegia after heart transplantation: outcomes at 1 year.
    Chan JL; Kobashigawa JA; Aintablian TL; Li Y; Perry PA; Patel JK; Kittleson MM; Czer LS; Zarrini P; Velleca A; Rush J; Arabia FA; Trento A; Esmailian F
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):212-217. PubMed ID: 28459983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prothrombin Complex Concentrate and Methylene Blue for Treatment of Coagulopathy and Vasoplegia in a Pediatric Heart Transplant Patient.
    Lee JK; Ing C
    A A Case Rep; 2016 Mar; 6(5):127-9. PubMed ID: 26599739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II: A Review of Current Literature.
    Alam A; Sovic W; Gill J; Ragula N; Salem M; Hughes GJ; Colbert GB; Mooney JL
    J Cardiothorac Vasc Anesth; 2022 Apr; 36(4):1180-1187. PubMed ID: 34452817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation.
    Tecson KM; Lima B; Lee AY; Raza FS; Ching G; Lee CH; Felius J; Baxter RD; Still S; Collier JDG; Hall SA; Joseph SM
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
    Gilbert M; Lema G
    Rev Med Chil; 2011 Mar; 139(3):368-72. PubMed ID: 21879171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasoplegia after pediatric cardiac transplantation in patients supported with a continuous flow ventricular assist device.
    Sacks LD; Hollander SA; Zhang Y; Ryan KR; Ford MA; Maeda K; Murray JM; Almond CS; Kwiatkowski DM
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2433-2440. PubMed ID: 30929985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock.
    Coleman PJ; Nissen AP; Kim DE; Ainsworth CR; McCurdy MT; Mazzeffi MA; Chow JH
    Semin Cardiothorac Vasc Anesth; 2020 Sep; 24(3):266-272. PubMed ID: 31540560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Multicenter Observational Cohort Study of Angiotensin II in Shock.
    Smith SE; Newsome AS; Guo Y; Hecht J; McCurdy MT; Mazzeffi MA; Chow JH; Kethireddy S
    J Intensive Care Med; 2022 Jan; 37(1):75-82. PubMed ID: 33231111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative Use of Angiotensin II for Severe Vasodilatory Shock During Liver Transplantation: A Case Report.
    Running K; Weinberg D; Trudo W; Sullivan CL; Patel GP
    A A Pract; 2021 Feb; 15(2):e01402. PubMed ID: 33577171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.